Cited by 279HIV-related health complications and treatmentsHIV Research and TreatmentHIV/AIDS Research and Interventions

. Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort.

Open access
Tien, Phyllis C, Choi, Andy I, Zolopa, Andrew R, Benson, Constance, Tracy, Russell, Scherzer, Rebecca, Bacchetti, Peter, Shlipak, Michael +1 more·2010·JAIDS Journal of Acquired Immune Deficiency Syndromes

Abstract

OBJECTIVE: To determine the association of inflammatory markers, fibrinogen, and C-reactive protein (CRP), with 5-year mortality risk. METHODS: Vital status was ascertained in 922 HIV-infected participants from the Study of Fat Redistribution and Metabolic Change in HIV infection. Multivariable logistic regression estimated odds ratios after adjustment for demographic, cardiovascular, and HIV-related factors. RESULTS: Over a 5-year period, HIV-infected participants with fibrinogen levels in the highest tertile (>406 mg/dL) had 2.6-fold higher adjusted odds of death than those with fibrinogen in the lowest tertile (<319 mg/dL). Those with high CRP (>3 mg/L) had 2.7-fold higher adjusted odds of death than those with CRP <1 mg/L. When stratified by CD4 count category, fibrinogen (as a linear variable) remained independently associated [odds ratio (95% confidence intervals)] per 100 mg/dL increase in fibrinogen: 1.93 (1.57 to 2.37); 1.43 (1.14 to 1.79); 1.43 (1.14 to 1.81); and 1.30 (1.04 to 1.63) for CD4 <200, 200-350, >350 to 500, and >500 cells per microliter, respectively. Higher CRP also remained associated with higher odds of death overall and within each CD4 subgroup. CONCLUSIONS: Fibrinogen and CRP are strong and independent predictors of mortality in HIV-infected adults. Our findings suggest that even in those with relatively preserved CD4 counts >500 cells per microliter, inflammation remains an important risk factor for mortality. Further investigation should determine whether interventions to reduce inflammation might decrease mortality risk in HIV-infected individuals.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/qai.0b013e3181e66216

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 28 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Tien, P. C., Choi, A. I., Zolopa, A. R., Benson, C., Tracy, R., Scherzer, R., Bacchetti, P., Shlipak, M., & Grunfeld, C.
Affiliations
  • San Francisco VA Medical Center (US)
  • Stanford Medicine (US)
  • University of California San Diego (US)
  • University of California, San Francisco (US)
Corresponding author
  • Tien, Phyllis C
  • Choi, Andy I
  • Scherzer, Rebecca
  • Shlipak, Michael
Venue
JAIDS Journal of Acquired Immune Deficiency Syndromes
Published
2010-11-01
Volume
55
Issue
3
Pages
316-322
ISSN
1525-4135 (ISSN-L)
OpenAlex
W2046166857
Cited by
279
References
28
Citations by year
2026: 3 · 2025: 6 · 2024: 3 · 2023: 10 · 2022: 16 · 2021: 17 · 2020: 15 · 2019: 13 · 2018: 18 · 2017: 21 · 2016: 26 · 2015: 23 · 2014: 24 · 2013: 31 · 2012: 25
FWCI
25.25
Type
journal article
Language
en
Open access
Locations
  • JAIDS Journal of Acquired Immune Deficiency Syndromes (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (2m01rr000083-41)
  • National Heart, Lung, and Blood Institute (HL-53359, R01HL053359, HL-74814, R01HL074814)
  • National Institute of Allergy and Infectious Diseases (K23AI066943)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK080645, R01DK057508, K23DK080645)
  • National Center for Research Resources (RR00054, UL1RR024131, RR-00051, RR 0636, M01RR000054, M01RR000051, RR 000 52, M01RR000052, M01-RR000083, RR00865, M01RR000865, RR 00083, M01RR000036)
Topics
  • Health Sciences › Medicine › Emergency Medicine › HIV-related health complications and treatments
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
Keywords
HIV infection, inflammation, mortality, fibrinogen, C-reactive protein, inflammatory markers, CD4 count, mortality risk factors
MeSH terms
Adult, C-Reactive Protein, Female, Fibrinogen, Humans, Inflammation, Male, Middle Aged, Prognosis, HIV Infections, Survival Analysis, CD4 Lymphocyte Count

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review